Получение и анти-ВИЧ активность β-галактозилсфингозина

Β-Galactosylsphingosine a potential anti-HIV agent, has been prepared from pig brain cerebrosides and tested for antiviral activity. HIV-inhibitory properties of this compound, predicted previously by molecular modeling, have been confirmed. Consequently, the glycolipid obtained is considered as a promising basic structure for designing its more efficient derivatives.На основе цереброзидов, выделенных из мозга свиньи, получен гликолипид β-галактозилсфингозин - потенциальный анти-ВИЧ-агент - и проведено его тестирование на противовирусную активность, которое подтвердило ВИЧ-ингибирующие свойства соединения, предсказанные ранее методами молекулярного моделирования. В связи с этим полученный гликолипид рассматривается как перспективная базовая структура для создания его более эффективных модифицированных форм

Epilepsy and pregnancy: current therapeutic tactics

The paper deals with the current tactics for managing epilepsy during pregnancy. Based on the data available in the literature and their extensive experience, the authors have developed and successfully introduced an observation scheme for pregnant women with epilepsy, stated contraindications for pregnancy, and determined the volume of clinical, laboratory, and instrumental studies, as well as observation frequency and the composition of specialists. Emphasis is placed on practical issues

Approaches for multi-tier cloud structure management

The number of IoT devices is constantly increasing every year. The volume of generated traffic is also increasing. Therefore, the new generation of 5G networks uses technology to reduce load and reverse delays-MEC. The MEC architecture is based on a multi-tier cloud structure, but official international documents do not define the principle at which architecture level a cloud computing is selected to manage the processing of user data. Therefore, in this article, we propose comparing three architectures for managing the choice of a cloud computing. It is proposed to implement a multi-tier cloud structure on the OpenStack platform. © 2019 IEEE

Синтез и люминесценция конъюгата фолиевой кислоты и хелата европия

We have synthesized a folic acid–europium complex conjugate which shows promise for biomedical applications. Мы синтезировали комплексный конъюгат фолиевой кислоты и европия, перспективный для биомедицинских применений

Phytochemical Analysis, Antibacterial and Antibiofilm Activities of <i>Aloe vera</i> Aqueous Extract against Selected Resistant Gram-Negative Bacteria Involved in Urinary Tract Infections

In bacterial infections, including urinary tract infections (UTIs), the gap between the development of new antimicrobials and antimicrobial resistance is dramatically increasing, especially in Gram-negative (Gram–) bacteria. All healthy products that can be used per se or that may be sources of antibacterial compounds should be considered in the fight against this major public health threat. In the present study, the phytochemical composition of Aloe vera extract was investigated by HPLC–MS/MS, and we further evaluated its antibacterial and antibiofilm formation activity against selected resistant Gram– bacteria involved in UTIs, namely, Achromobacter xylosoxidans 4892, Citrobacter freundii 426, Escherichia coli 1449, Klebsiella oxytoca 3003, Moraxella catarrhalis 4222, Morganella morganii 1543, Pseudomonas aeruginosa 3057, and a reference strain E. coli ATCC 25922. Inhibition zones (IZs) of the extract were determined using the well diffusion method, minimum inhibitory (MIC), and bactericidal (MBC) concentration by the two-fold serial microdilution assay, and antibiofilm formation activity by the crystal violet attachment assay. Aloe-emodin and its derivatives were the major constituent (75.74%) of A. vera extract, the most important of them being aloesin (30.22%), aloe-emodin-diglucoside (12.58%), and 2′-p-methoxycoumaroylaloeresin B (9.64%). The minerals found in the extract were sulfur (S), silicon (Si), chlorine (Cl), potassium (K), and bromine (Br). Except for the clinical strain E. coli 1449, which was totally non-susceptible, A. vera demonstrated noteworthy antibacterial activity with MIC and MBC values ranging from 0.625 to 5 mg/mL and 5 to 10 mg/mL, respectively. A. vera also demonstrated dose-dependent antibacterial effects, and the reference strain E. coli ATCC 25922 was the most susceptible with MIC = 0.625 and IZ = 19 mm at 20 mg/mL. The antibiofilm formation potential of A. vera extract was strong at 2MIC and MIC (93–100% of biofilm formation inhibition), moderate at MIC/2 (32–41%), weak at MIC/4 (14–21%), and nil at MIC/8

Measurement of charged-particle multiplicities in gluon and quark jets in p(p)over-bar collisions at root s=1.8 TeV

We report the first largely model independent measurement of charged particle multiplicities in quark and gluon jets, N-q and N-g, produced at the Fermilab Tevatron in p (p) over bar collisions with a center-of-mass energy of 1.8 TeV and recorded by the Collider Detector at Fermilab. The measurements are made for jets with average energies of 41 and 53 GeV by counting charged particle tracks in cones with opening angles of θ(c)=0.28, 0.36, and 0.47 rad around the jet axis. The corresponding jet hardness Q=E-jetθ(c) varies in the range from 12 to 25 GeV. At Q=19.2 GeV, the ratio of multiplicities r=N-g/N-q is found to be 1.64&PLUSMN; 0.17, where statistical and systematic uncertainties are added in quadrature. The results are in agreement with resummed perturbative QCD calculations